Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.23B | 1.22B | 1.21B | 1.22B | 1.22B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23B | 1.22B | 1.21B | 1.22B | 1.22B |
| Cost of Revenue | 415.48M | 410.16M | 406.84M | 405.94M | 403.53M |
| Gross Profit | 812.71M | 804.88M | 803.97M | 809.63M | 813.20M |
| SG&A Expenses | 449.41M | 435.56M | 439.23M | 482.68M | 491.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 961.76M | 940.49M | 942.92M | 986.60M | 995.38M |
| Operating Income | 266.43M | 274.55M | 267.89M | 228.98M | 221.35M |
| Income Before Tax | 227.38M | 240.68M | 147.14M | 114.19M | 106.28M |
| Income Tax Expenses | 55.41M | 58.82M | 37.58M | 33.09M | 28.30M |
| Earnings from Continuing Operations | 171.97 | 181.86 | 109.56 | 81.10 | 77.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 171.97M | 181.86M | 109.56M | 81.10M | 77.99M |
| EBIT | 266.43M | 274.55M | 267.89M | 228.98M | 221.35M |
| EBITDA | 363.18M | 371.91M | 368.22M | 332.71M | 327.45M |
| EPS Basic | 1.10 | 1.17 | 0.70 | 0.52 | 0.50 |
| Normalized Basic EPS | 1.04 | 1.08 | 1.05 | 0.91 | 0.87 |
| EPS Diluted | 1.09 | 1.15 | 0.68 | 0.50 | 0.48 |
| Normalized Diluted EPS | 1.03 | 1.07 | 1.04 | 0.90 | 0.86 |
| Average Basic Shares Outstanding | 625.06M | 623.72M | 622.54M | 623.59M | 626.18M |
| Average Diluted Shares Outstanding | 629.36M | 627.79M | 626.52M | 628.06M | 631.69M |
| Dividend Per Share | 0.24 | 0.32 | 0.32 | 0.32 | 0.32 |
| Payout Ratio | 29.09% | 27.45% | 45.47% | 61.50% | 64.30% |